Sanela Bilic

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Safety and Efficacy of Apitegromab in Patients With Spinal Muscular Atrophy Types 2 and 3”.

Safety and Efficacy of Apitegromab in Patients With Spinal Muscular Atrophy Types 2 and 3

Neurology(2024)10.1212/wnl.0000000000209151

N/A

2.4DataRank · unranked

44 citations

Basil T. Darras, John Day, Sally Dunaway Young, Tina Duong, Leslie Nelson +14 more

Refined cut-off for TP53 immunohistochemistry improves prediction of TP53 mutation status in ovarian mucinous tumors: implications for outcome analyses

Modern Pathology(2020)10.1038/s41379-020-0618-9

N/A

1.3DataRank · unranked

43 citations

Dane Cheasley, Cécile Le Page, Matthew J. Wakefield, Michelle da Cunha Torres, Simone M. Rowley +93 more

MCM3 is a novel proliferation marker associated with longer survival for patients with tubo-ovarian high-grade serous carcinoma

Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin(2021)10.1007/s00428-021-03232-0

N/A

0.477DataRank · unranked

23 citations

Joshua Millstein, Gordana Popović, Nicola S. Meagher, Adelyn Bolithon, Aline Talhouk +95 more